Wexiong Xu

15PUBLICATIONS
40CO-AUTHORS
Respiratory diseasesBehavioural epidemiologyMolecular targetsGastroenterology and hepatologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 07, 2026
Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial.

|Jan 29, 2026
Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

Qiumin Luo, Wenxiong Xu, Yeqiong Zhang

|Aug 11, 2025
Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma.

Chan Xie, Xingrong Zheng, Songmin He

|Jul 17, 2025
Comparative Cost-Effectiveness of Two Artificial Liver Therapies in Early-Stage Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Retrospective Cohort Study.

Jia Chen, Qiumin Luo, Lu Wang

|Nov 24, 2022
High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.

Wenxiong Xu, Yanlin Huang, Yongyu Mei

|Nov 16, 2022
The relationship between zinc deficiency and infectious complications in patients with hepatitis B virus-related acute-on-chronic liver failure.

Xinhua Li, Lu Wang, Na He

Pageof 3

Frequent Collaborators

11 joint publications

Liang Peng

3 joint publications

Chan Xie

3 joint publications

Yongyu Mei

3 joint publications

Chan Xie